Enfusion, Inc. (“Enfusion”) (NYSE:ENFN), a leading provider of cloud-based investment management software and services, today announced that its Board of Directors (the “Board”) has appointed Oleg Movchan, currently a member of the Board, as Interim Chief Executive Officer, effective August 21, 2022. Mr. Movchan succeeds Thomas Kim, who has resigned as CEO and as a Director of the Company so that he can spend more time with his family.
GLJ Research Initiates Coverage On Sunrun with Sell Rating
GLJ Research analyst Gordon Johnson initiates coverage on Sunrun (NASDAQ:RUN) with a Sell rating.
